International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Hopelessness Scores and Urine Tests in Patients With Methadone Maintenance Therapy

Gamal Sadek 1 , Zack Cernovsky 2 , * and Simon Chiu 2
Authors Information
1 Methadone Clinic, London, Ontario, Canada
2 Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
Article information
  • International Journal of High Risk Behaviors and Addiction: March 2018, 7 (1); e67612
  • Published Online: February 26, 2018
  • Article Type: Brief Report
  • Received: January 11, 2016
  • Revised: September 9, 2016
  • Accepted: February 25, 2017
  • DOI: 10.5812/ijhrba.67612

To Cite: Sadek G, Cernovsky Z, Chiu S. Hopelessness Scores and Urine Tests in Patients With Methadone Maintenance Therapy, Int J High Risk Behav Addict. 2018 ;7(1):e67612. doi: 10.5812/ijhrba.67612.

Abstract
Copyright © 2018, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Aghayan S, Amiri M, Chaman R, Khosravi A. Quality of Life in Methadone Maintenance Treated Patients in Iran. Int J High Risk Behav Addict. 2015;4(4). e22275. doi: 10.5812/ijhrba.22275. [PubMed: 26870708].
  • 2. Wilcox HC, Conner KR, Caine ED. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend. 2004;76 Suppl:S11-9. doi: 10.1016/j.drugalcdep.2004.08.003. [PubMed: 15555812].
  • 3. Darke S, Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction. 2002;97(11):1383-94. [PubMed: 12410779].
  • 4. Steeg S, Haigh M, Webb RT, Kapur N, Awenat Y, Gooding P, et al. The exacerbating influence of hopelessness on other known risk factors for repeat self-harm and suicide. J Affect Disord. 2016;190:522-8. doi: 10.1016/j.jad.2015.09.050. [PubMed: 26561943].
  • 5. Beck AT. Beck Hopelessness Scale. San Antonio: The Psychological Corporation; 1988.
  • 6. Mokhber N, Afshari R, Farhoodi F. Evaluation of the suicide risk factors among methadone maintenance treatment of opiate dependent individuals: A six month assessment. Open J Psychiat. 2012;2(2):91-5.
  • 7. Beck JS. Cognitive Behavior Therapy. 2nd Edition ed. New York: The Guilford Press; 2011.
  • 8. Pagano RR. Understanding Statistics in The Behavioral Sciences. New York: West Publishing Co; 1986.
  • 9. Downie NM, Heath RW. Basic Statistical Methods. New York: Harper and Row; 1974.
  • 10. Brizer DA, Hartman N, Sweeney J, Millman RB. Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia. Am J Psychiatry. 1985;142(9):1106-7. doi: 10.1176/ajp.142.9.1106. [PubMed: 2862800].
  • 11. Maremmani I, Pacini M, Canoniero S, Deltito J, Maremmani AG, Tagliamonte A. Dose determination in dual diagnosed heroin addicts during methadone treatment. Heroin Addict Relat Clinical Prob. 2010;12(1):17-24.
  • 12. Maremmani AG, Rovai L, Pani PP, Pacini M, Lamanna F, Rugani F, et al. Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts? Ann Gen Psychiatry. 2011;10:17. doi: 10.1186/1744-859X-10-17. [PubMed: 21569624].
  • 13. Khazaal Y, Despland JN, Currat T, Zullino DF. Obsessive-compulsive symptoms precipitated by methadone tapering. J Clin Psychopharmacol. 2004;24(6):682-3. [PubMed: 15538140].
  • 14. Khazaal Y, Krenz S, Benmebarek M, Zullino DF. Worsening of obsessive-compulsive symptoms under methadone tapering. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(7):1350-2. doi: 10.1016/j.pnpbp.2006.03.001. [PubMed: 16630677].
  • 15. Sadek GE, Cernovsky ZZ. Case Report Of OCD Worsening When Methadone Tapered Below 7.5 mg. Internet J Psychiat. 2014;3(1).
  • 16. Sharpe PC. Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem. 2001;38(Pt 6):652-64. doi: 10.1258/0004563011901064. [PubMed: 11732647].
  • 17. Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, et al. A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. Am J Addict. 2015;24(7):613-20. doi: 10.1111/ajad.12273. [PubMed: 26331953].
  • 18. Fudalej S, Ilgen M, Kolodziejczyk I, Podgorska A, Serafin P, Barry K, et al. Somatic Comorbidity and Other Factors Related to Suicide Attempt Among Polish Methadone Maintenance Patients. J Addict Med. 2015;9(6):433-9. doi: 10.1097/ADM.0000000000000153. [PubMed: 26335004].
  • 19. Michel L, Lions C, Maradan G, Mora M, Marcellin F, Morel A, et al. Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville). Compr Psychiatry. 2015;62:123-31. doi: 10.1016/j.comppsych.2015.07.004. [PubMed: 26343476].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments